Nemaura Medical Inc.
NMRD · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | – | – | 100% | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | – | – | – | 295.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | 144.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | 21.1% |
| EPS Diluted | -0.075 | -0.042 | -0.09 | -0.013 |
| % Growth | -79.8% | 53.8% | -582.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |